UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007840
Receipt number R000009242
Scientific Title A clinical trial to evaluate iron preparation effect for the pulmonary hypertension secondary in chronic respiratory disease patients
Date of disclosure of the study information 2012/04/26
Last modified on 2014/02/28 20:57:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A clinical trial to evaluate iron preparation effect for the pulmonary hypertension secondary in chronic respiratory disease patients

Acronym

Secondary PH-Fe study

Scientific Title

A clinical trial to evaluate iron preparation effect for the pulmonary hypertension secondary in chronic respiratory disease patients

Scientific Title:Acronym

Secondary PH-Fe study

Region

Japan


Condition

Condition

Chronic respiratory failure patients with pulmonary arterial hypertension

Classification by specialty

Cardiology Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Chronic respiratory failure patients with pulmonary hypertension receive iron preparation load and we examine short-term effect to pulmonary arterial pressure

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

TR-PG level by the heart ultrasonography

Key secondary outcomes

PaO2 level, reticulocyte count, NT-pro BNP level, hematocrit, mean concentration hematocrit (MCH), mean corpuscular hemoglobin concentration (MCHC)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

infusion by saccharatedferric oxide

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Chronic respiratory failure patients
2.Less than Hb 16mg/dl
3.Lower than ferritin level 500ng/ml
4.TR -PG level is more than 32torr in heart ultrasonography findings
5.Age is 60 years old or older
6.Patients receive enough explanation about this study, and patients who provide their written informed consent to participate in this study.

Key exclusion criteria

1.Patient's fever is 38 degrees or more within one week before screening test
2.Patients complicated with active tuberculosis and atypical mycobacterial disease
3.Patients with active respiratory tract infection in chest Xp or clinical examination
4.Patients with active heart failure with the hemostatic findings in chest Xp
**But, we make it possible to conduct a screening test after hemostatic findings disappeared in case that recognized hemostatic findings in chest X-rays.
5.Patients with pneumothorax in chest Xp
6.Patients with pleural effusion that drainage needs
7.Patients with history of hypersensitivity with iron preparation formulation
8.Patients who are complicated with apparent hepatic cirrhosis or active hepatitis
9.Patients with history of paroxysmal nocturnal hemoglobinemia
10.Patients with apparent renal failure
11.The patients in acknowledgment of exacerbation with existing illness within one month from screening test
12.A pregnant woman or the patients with the possibility to become pregnant and nursing patients
13.In addition, the patients whom doctor attending judged to be inadequate as a study candidate

Target sample size

41


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Mitsuhiro Sumitani

Organization

Osaka City Gerenal Hospital

Division name

Respiratory Medicine

Zip code


Address

2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka

TEL

06-6929-1221

Email

sumytany@nifty.com


Public contact

Name of contact person

1st name
Middle name
Last name Mitsuhiro Sumitani

Organization

Osaka City Gerenal Hospital

Division name

Respiratory Medicine

Zip code


Address

2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka

TEL

06-6929-1221

Homepage URL


Email

sumytany@nifty.com


Sponsor or person

Institute

Osaka City General Hospital
Department of Respiratory Medicine

Institute

Department

Personal name



Funding Source

Organization

Osaka City General Hospital
Department of Respiratory Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

伊勢赤十字病院(三重県)


Other administrative information

Date of disclosure of the study information

2012 Year 04 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2011 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2011 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry

2014 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 04 Month 26 Day

Last modified on

2014 Year 02 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009242


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name